June 18, 2012
“The hardball question was thrown during the Q&A with the judges who had been drilling Michael Schrader on the scientific and regulatory implications of his business pitch.
Schrader, 29, a second-year Harvard Business School student, already had effortlessly handled his 15-minute pitch for the school’s Business Plan Competition on Tuesday afternoon (April 24). It was no easy task because the idea he and his six teammates were trying to sell is fairly complicated.
Their startup, Vaxess Technologies, is working to commercialize Tufts University knowhow using a protein derived from silk. The technology stabilizes vaccines into a thin film strip which can be shipped and stored without refrigeration, increasing access to life-saving products for people all around the world…”